BayOConnect 2025

Save the date for 30 June - 1 July 2026!

This was #BayOConnect2025 in Munich on 1 - 2 July 2025! Photo Gallery

BayOConnect 2025: Bavaria shows great biomedical innovation potential in dynamic times

Discussed the future of global biotechnology in dynamic times (fltr): Kevin Peters, Managing Director, MSD Sharp & Dohme, Han Steutel, President Verband Forschender Arzneimittelhersteller e.V. (vfa), Dr. Laura Matz, Chief Science and Technology Officer, Merck KGaA, Prof. Dr. Francis de Véricourt, Institute for Deep Tech Innovation (DEEP) at the European School of Management and Technology Berlin, and Prof. Dr. Ralf Huss, Managing Director BioM. Copyright: © BioM / Bert Willer

Biotechnology conference “BayOConnect” in Munich brings together players from all areas of Bavarian and international biotechnology.

With around 350 participants, over 350 partnering meetings, 10 start-up pitches and 16 poster presentations, 27 exhibitors and over 40 sponsors and partners, Bio^M successfully promotes networking in the industry.

Geopolitics, macroeconomic uncertainties and changing framework conditions influence biotech developments and investment behavior.

Accelerating life science research and development requires new incentives, strategic models and international cooperation.

Start-up 2NA FISH wins BayOConnect Start-up Award sponsored by EBD Group.

m⁴Award ceremony: 2.5 million euros for five research teams from Bavaria.

Around 350 players from the Bavarian, German and international biotechnology industry responded to the call of the biotech cluster development organization Bio^M to attend the 2nd edition of the biotechnology conference “BayOConnect - Forum for Biotech & LifeScience” in Munich. On July 1 and 2, big players, SMEs, start-ups, science, pharmaceuticals, politics and investors met to exchange ideas. The industry discussed the changing framework conditions for innovation in dynamic times. Start-ups presented new ideas on innovative gene therapy, RNA targeting and non-invasive cancer diagnostics, among other things. The conference concluded with the ceremonial presentation of the m⁴Award, endowed with 2.5 million euros, to 5 Bavarian teams for outstanding biomedical research. ... [read more]

As a central platform, BayOConnect brings together visionary thinkers, innovative companies, and life science enthusiasts from the Bavarian biotech landscape and around the world to accelerate the progress of biotechnology in healthcare and medicine.

This unique event offers the unparalleled opportunity to connect directly with key players in biotechnological innovation and entrepreneurship, uncover groundbreaking developments, and dive into the dynamic future of biotechnology in Bavaria.

BayOConnect opens doors to an ecosystem focused on innovation, growth, and collective success. Seize the opportunity to learn about the latest trends and applications in biotechnology, make valuable contacts, and forge partnerships that pave the way for new projects and ventures.

Your Benefits:

Dive into the intersection of cutting-edge biopharmaceuticals, Artificial Intelligence, data science, nanotechnology and more.
Immerse yourself in dynamic keynotes, hands-on workshops, and a thrilling start-up pitch.
Connect with industry leaders, investors, visionary scientists
Explore the potential of innovation in the heart of Europe's biotech hub.

Don't miss your chance to be part of the conversation, shaping the future of biotech and AI. Experience the dynamic vibe of the Bavarian biotech ecosystem!

Supported by: